Cargando…

Quality-of-Life Outcomes following Thoracolumbar and Lumbar Fusion with and without the Use of Recombinant Human Bone Morphogenetic Protein-2: Does Recombinant Human Bone Morphogenetic Protein-2 Make a Difference?

Design Retrospective study. Objectives (1) To investigate the quality-of-life (QOL) outcomes in the population undergoing lumbar spine surgery with versus without recombinant human bone morphogenetic protein-2 (rhBMP-2); (2) to determine QOL outcomes for those patients who experience postoperative c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lubelski, Daniel, Alvin, Matthew D., Torre-Healy, Andrew, Abdullah, Kalil G., Nowacki, Amy S., Whitmore, Robert G., Steinmetz, Michael P., Benzel, Edward C., Mroz, Thomas E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229380/
https://www.ncbi.nlm.nih.gov/pubmed/25396105
http://dx.doi.org/10.1055/s-0034-1394123
_version_ 1782344129939767296
author Lubelski, Daniel
Alvin, Matthew D.
Torre-Healy, Andrew
Abdullah, Kalil G.
Nowacki, Amy S.
Whitmore, Robert G.
Steinmetz, Michael P.
Benzel, Edward C.
Mroz, Thomas E.
author_facet Lubelski, Daniel
Alvin, Matthew D.
Torre-Healy, Andrew
Abdullah, Kalil G.
Nowacki, Amy S.
Whitmore, Robert G.
Steinmetz, Michael P.
Benzel, Edward C.
Mroz, Thomas E.
author_sort Lubelski, Daniel
collection PubMed
description Design Retrospective study. Objectives (1) To investigate the quality-of-life (QOL) outcomes in the population undergoing lumbar spine surgery with versus without recombinant human bone morphogenetic protein-2 (rhBMP-2); (2) to determine QOL outcomes for those patients who experience postoperative complications; and (3) to identify the effect of patient characteristics on postoperative QOL outcomes. Methods A retrospective review of QOL questionnaires, including the Patient Health Questionnaire-9, Patient Disability Questionnaire (PDQ), EuroQol-5D (EQ-5D), and quality of life-year (QALY), was performed for all patients who underwent thoracolumbar and lumbar fusion surgery with versus without rhBMP-2 between March 2008 and September 2010. Individual preoperative and postoperative QOL data were compared for each patient. Demographic factors and complications were reviewed. Results We identified 266 patients, including 60 with and 206 without rhBMP-2. Questionnaires were completed an average of 10.3 ± 5 months after surgery. For all measures, average scores improved postoperatively compared with preoperatively. No differences in postoperative QOL outcomes were identified between the rhBMP-2 and the control cohorts. Median annual household income was positively associated with EQ-5D and QALY. Compared with those without, patients with postoperative complications had fewer QOL improvements. Conclusions There was no difference in QOL outcomes in the rhBMP-2 compared with the control group. Socioeconomic status and postoperative complications affected QOL outcomes following surgery. The QOL questionnaires provide the clinician with information regarding the patients' self-perceived well-being and can be helpful in the selection of surgical candidates and for understanding the effectiveness of a given surgical procedure.
format Online
Article
Text
id pubmed-4229380
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-42293802015-03-11 Quality-of-Life Outcomes following Thoracolumbar and Lumbar Fusion with and without the Use of Recombinant Human Bone Morphogenetic Protein-2: Does Recombinant Human Bone Morphogenetic Protein-2 Make a Difference? Lubelski, Daniel Alvin, Matthew D. Torre-Healy, Andrew Abdullah, Kalil G. Nowacki, Amy S. Whitmore, Robert G. Steinmetz, Michael P. Benzel, Edward C. Mroz, Thomas E. Global Spine J Article Design Retrospective study. Objectives (1) To investigate the quality-of-life (QOL) outcomes in the population undergoing lumbar spine surgery with versus without recombinant human bone morphogenetic protein-2 (rhBMP-2); (2) to determine QOL outcomes for those patients who experience postoperative complications; and (3) to identify the effect of patient characteristics on postoperative QOL outcomes. Methods A retrospective review of QOL questionnaires, including the Patient Health Questionnaire-9, Patient Disability Questionnaire (PDQ), EuroQol-5D (EQ-5D), and quality of life-year (QALY), was performed for all patients who underwent thoracolumbar and lumbar fusion surgery with versus without rhBMP-2 between March 2008 and September 2010. Individual preoperative and postoperative QOL data were compared for each patient. Demographic factors and complications were reviewed. Results We identified 266 patients, including 60 with and 206 without rhBMP-2. Questionnaires were completed an average of 10.3 ± 5 months after surgery. For all measures, average scores improved postoperatively compared with preoperatively. No differences in postoperative QOL outcomes were identified between the rhBMP-2 and the control cohorts. Median annual household income was positively associated with EQ-5D and QALY. Compared with those without, patients with postoperative complications had fewer QOL improvements. Conclusions There was no difference in QOL outcomes in the rhBMP-2 compared with the control group. Socioeconomic status and postoperative complications affected QOL outcomes following surgery. The QOL questionnaires provide the clinician with information regarding the patients' self-perceived well-being and can be helpful in the selection of surgical candidates and for understanding the effectiveness of a given surgical procedure. Georg Thieme Verlag KG 2014-10-10 2014-12 /pmc/articles/PMC4229380/ /pubmed/25396105 http://dx.doi.org/10.1055/s-0034-1394123 Text en © Thieme Medical Publishers
spellingShingle Article
Lubelski, Daniel
Alvin, Matthew D.
Torre-Healy, Andrew
Abdullah, Kalil G.
Nowacki, Amy S.
Whitmore, Robert G.
Steinmetz, Michael P.
Benzel, Edward C.
Mroz, Thomas E.
Quality-of-Life Outcomes following Thoracolumbar and Lumbar Fusion with and without the Use of Recombinant Human Bone Morphogenetic Protein-2: Does Recombinant Human Bone Morphogenetic Protein-2 Make a Difference?
title Quality-of-Life Outcomes following Thoracolumbar and Lumbar Fusion with and without the Use of Recombinant Human Bone Morphogenetic Protein-2: Does Recombinant Human Bone Morphogenetic Protein-2 Make a Difference?
title_full Quality-of-Life Outcomes following Thoracolumbar and Lumbar Fusion with and without the Use of Recombinant Human Bone Morphogenetic Protein-2: Does Recombinant Human Bone Morphogenetic Protein-2 Make a Difference?
title_fullStr Quality-of-Life Outcomes following Thoracolumbar and Lumbar Fusion with and without the Use of Recombinant Human Bone Morphogenetic Protein-2: Does Recombinant Human Bone Morphogenetic Protein-2 Make a Difference?
title_full_unstemmed Quality-of-Life Outcomes following Thoracolumbar and Lumbar Fusion with and without the Use of Recombinant Human Bone Morphogenetic Protein-2: Does Recombinant Human Bone Morphogenetic Protein-2 Make a Difference?
title_short Quality-of-Life Outcomes following Thoracolumbar and Lumbar Fusion with and without the Use of Recombinant Human Bone Morphogenetic Protein-2: Does Recombinant Human Bone Morphogenetic Protein-2 Make a Difference?
title_sort quality-of-life outcomes following thoracolumbar and lumbar fusion with and without the use of recombinant human bone morphogenetic protein-2: does recombinant human bone morphogenetic protein-2 make a difference?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229380/
https://www.ncbi.nlm.nih.gov/pubmed/25396105
http://dx.doi.org/10.1055/s-0034-1394123
work_keys_str_mv AT lubelskidaniel qualityoflifeoutcomesfollowingthoracolumbarandlumbarfusionwithandwithouttheuseofrecombinanthumanbonemorphogeneticprotein2doesrecombinanthumanbonemorphogeneticprotein2makeadifference
AT alvinmatthewd qualityoflifeoutcomesfollowingthoracolumbarandlumbarfusionwithandwithouttheuseofrecombinanthumanbonemorphogeneticprotein2doesrecombinanthumanbonemorphogeneticprotein2makeadifference
AT torrehealyandrew qualityoflifeoutcomesfollowingthoracolumbarandlumbarfusionwithandwithouttheuseofrecombinanthumanbonemorphogeneticprotein2doesrecombinanthumanbonemorphogeneticprotein2makeadifference
AT abdullahkalilg qualityoflifeoutcomesfollowingthoracolumbarandlumbarfusionwithandwithouttheuseofrecombinanthumanbonemorphogeneticprotein2doesrecombinanthumanbonemorphogeneticprotein2makeadifference
AT nowackiamys qualityoflifeoutcomesfollowingthoracolumbarandlumbarfusionwithandwithouttheuseofrecombinanthumanbonemorphogeneticprotein2doesrecombinanthumanbonemorphogeneticprotein2makeadifference
AT whitmorerobertg qualityoflifeoutcomesfollowingthoracolumbarandlumbarfusionwithandwithouttheuseofrecombinanthumanbonemorphogeneticprotein2doesrecombinanthumanbonemorphogeneticprotein2makeadifference
AT steinmetzmichaelp qualityoflifeoutcomesfollowingthoracolumbarandlumbarfusionwithandwithouttheuseofrecombinanthumanbonemorphogeneticprotein2doesrecombinanthumanbonemorphogeneticprotein2makeadifference
AT benzeledwardc qualityoflifeoutcomesfollowingthoracolumbarandlumbarfusionwithandwithouttheuseofrecombinanthumanbonemorphogeneticprotein2doesrecombinanthumanbonemorphogeneticprotein2makeadifference
AT mrozthomase qualityoflifeoutcomesfollowingthoracolumbarandlumbarfusionwithandwithouttheuseofrecombinanthumanbonemorphogeneticprotein2doesrecombinanthumanbonemorphogeneticprotein2makeadifference